{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T01:31:01Z","timestamp":1793669461150,"version":"4.5.1"},"reference-count":60,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T00:00:00Z","timestamp":1738800000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA235026"],"award-info":[{"award-number":["R01CA235026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA254951"],"award-info":[{"award-number":["R01CA254951"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA235026"],"award-info":[{"award-number":["R01CA235026"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"U.S. Department of Health & Human Services | National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA254951"],"award-info":[{"award-number":["R01CA254951"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Blood Cancer J."],"DOI":"10.1038\/s41408-024-01207-3","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T02:23:01Z","timestamp":1738808581000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Genomic characterization of chronic lymphocytic leukemia in patients of African ancestry"],"prefix":"10.1038","volume":"15","author":[{"given":"Cecilia","family":"Bonolo de Campos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal E.","family":"McCabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura A.","family":"Bruins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R.","family":"O\u2019Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sochilt","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renee C.","family":"Tschumper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristine","family":"Allmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan Xiao","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7313-1875","authenticated-orcid":false,"given":"Kari G.","family":"Rabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3221-7314","authenticated-orcid":false,"given":"Sameer A.","family":"Parikh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5951-5055","authenticated-orcid":false,"given":"Neil E.","family":"Kay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0756-2922","authenticated-orcid":false,"given":"Huihuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7482-178X","authenticated-orcid":false,"given":"James R.","family":"Cerhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John N.","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1677-7626","authenticated-orcid":false,"given":"Richard R.","family":"Furman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J. Brice","family":"Weinberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle M.","family":"Brander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane F.","family":"Jelinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4024-8225","authenticated-orcid":false,"given":"Marta","family":"Chesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5173-4712","authenticated-orcid":false,"given":"Susan L.","family":"Slager","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3860-4830","authenticated-orcid":false,"given":"Esteban","family":"Braggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,2,6]]},"reference":[{"key":"1207_CR1","doi-asserted-by":"publisher","unstructured":"American Cancer Society. Cancer facts & figures 2022. Atlanta, Ga: American Cancer Society; 2022. https:\/\/doi.org\/10.3238\/arztebl.2008.0255.","DOI":"10.3238\/arztebl.2008.0255"},{"key":"1207_CR2","doi-asserted-by":"publisher","first-page":"2745","DOI":"10.1182\/blood-2017-09-806398","volume":"131","author":"M Hallek","year":"2018","unstructured":"Hallek M, Cheson BD, Catovsky D, Caligaris-Cappio F, Dighiero G, D\u00f6hner H, et al. iwCLL guidelines for diagnosis, indications for treatment, response assessment, and supportive management of CLL. Blood. 2018;131:2745\u201360.","journal-title":"Blood"},{"key":"1207_CR3","doi-asserted-by":"publisher","DOI":"10.1038\/nrdp.2016.96","volume":"3","author":"TJ Kipps","year":"2017","unstructured":"Kipps TJ, Stevenson FK, Wu CJ, Croce CM, Packham G, Wierda WG, et al. Chronic lymphocytic leukaemia. Nat Rev Dis Primers. 2017;3:16096.","journal-title":"Nat Rev Dis Primers"},{"key":"1207_CR4","doi-asserted-by":"crossref","unstructured":"Slager SL, Benavente Y, Blair A, Vermeulen R, Cerhan JR, Costantini AS, et al. Medical history, lifestyle, family history, and occupational risk factors for chronic lymphocytic leukemia\/small lymphocytic lymphoma: the InterLymph non-Hodgkin lymphoma subtypes project. J Natl Cancer Inst Monogr. 2014;2014:41\u201351.","DOI":"10.1093\/jncimonographs\/lgu001"},{"key":"1207_CR5","doi-asserted-by":"publisher","first-page":"868","DOI":"10.1038\/ng.2652","volume":"45","author":"SI Berndt","year":"2013","unstructured":"Berndt SI, Skibola CF, Joseph V, Camp NJ, Nieters A, Wang Z, et al. Genome-wide association study identifies multiple risk loci for chronic lymphocytic leukemia. Nat Genet. 2013;45:868\u201376.","journal-title":"Nat Genet"},{"key":"1207_CR6","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14175","volume":"8","author":"PJ Law","year":"2017","unstructured":"Law PJ, Berndt SI, Speedy HE, Camp NJ, Sava GP, Skibola CF, et al. Genome-wide association analysis implicates dysregulation of immunity genes in chronic lymphocytic leukaemia. Nat Commun. 2017;8:14175.","journal-title":"Nat Commun"},{"key":"1207_CR7","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms10933","volume":"7","author":"SI Berndt","year":"2016","unstructured":"Berndt SI, Camp NJ, Skibola CF, Vijai J, Wang Z, Gu J, et al. Meta-analysis of genome-wide association studies discovers multiple loci for chronic lymphocytic leukemia. Nat Commun. 2016;7:10933.","journal-title":"Nat Commun"},{"key":"1207_CR8","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1182\/blood-2012-02-408799","volume":"120","author":"CC Coombs","year":"2012","unstructured":"Coombs CC, Rassenti LZ, Falchi L, Slager SL, Strom SS, Ferrajoli A, et al. Single nucleotide polymorphisms and inherited risk of chronic lymphocytic leukemia among African Americans patients ascertained at Duke University. Blood. 2012;120:1687\u201391.","journal-title":"Blood"},{"key":"1207_CR9","doi-asserted-by":"publisher","first-page":"2835","DOI":"10.1038\/s41375-022-01711-0","volume":"36","author":"SI Berndt","year":"2022","unstructured":"Berndt SI, Vijai J, Benavente Y, Camp NJ, Nieters A, Wang Z, et al. Distinct germline genetic susceptibility profiles identified for common non-Hodgkin lymphoma subtypes. Leukemia. 2022;36:2835\u201344.","journal-title":"Leukemia"},{"key":"1207_CR10","unstructured":"National Cancer Institute. SEER Cancer stat facts: leukemia\u2014chronic lymphocytic leukemia (CLL). 2022. https:\/\/seer.cancer.gov\/statfacts\/html\/clyl.html."},{"key":"1207_CR11","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-19081-4","volume":"8","author":"Y Zhao","year":"2018","unstructured":"Zhao Y, Wang Y, Ma S. Racial differences in four leukemia subtypes: comprehensive descriptive epidemiology. Sci Rep. 2018;8:548.","journal-title":"Sci Rep"},{"key":"1207_CR12","doi-asserted-by":"publisher","first-page":"699","DOI":"10.1016\/j.clml.2019.06.009","volume":"19","author":"AA Ayers","year":"2019","unstructured":"Ayers AA, Lyu L, Dance K, Ward KC, Flowers CR, Koff JL, et al. Characterizing lymphoma incidence and disparities for a cancer center catchment region. Clin Lymphoma Myeloma Leuk. 2019;19:699\u2013708.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1207_CR13","doi-asserted-by":"publisher","first-page":"2575","DOI":"10.1182\/bloodadvances.2022008643","volume":"7","author":"AS Kittai","year":"2023","unstructured":"Kittai AS, Huang Y, Bhat SA, Paskett ED, Rogers KA, Barrientos JC, et al. Racial and socioeconomic disparities in CLL\/SLL: analysis of SEER data from 2006 to 2019. Blood Adv. 2023;7:2575\u20139.","journal-title":"Blood Adv"},{"key":"1207_CR14","doi-asserted-by":"publisher","first-page":"E172","DOI":"10.1002\/ajh.26937","volume":"98","author":"VA Vardell","year":"2023","unstructured":"Vardell VA, Ermann DA, Fitzgerald LA, Shah HR, Hu B, Stephens DM. Influence of racial and ethnic identity on overall survival in patients with chronic lymphocytic leukemia. Am J Hematol. 2023;98:E172\u2013E174.","journal-title":"Am J Hematol"},{"key":"1207_CR15","doi-asserted-by":"publisher","first-page":"3177","DOI":"10.1002\/cncr.28030","volume":"119","author":"L Falchi","year":"2013","unstructured":"Falchi L, Keating MJ, Wang X, Coombs CC, Lanasa MC, Strom S, et al. Clinical characteristics, response to therapy, and survival of African American patients diagnosed with chronic lymphocytic leukemia. Cancer. 2013;119:3177\u201385.","journal-title":"Cancer"},{"key":"1207_CR16","doi-asserted-by":"publisher","first-page":"2326","DOI":"10.3109\/10428194.2012.698276","volume":"53","author":"CC Coombs","year":"2012","unstructured":"Coombs CC, Falchi L, Weinberg JB, Ferrajoli A, Lanasa MC. Chronic lymphocytic leukemia in African Americans. Leuk Lymphoma. 2012;53:2326\u20139.","journal-title":"Leuk Lymphoma"},{"key":"1207_CR17","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.clml.2011.07.002","volume":"11","author":"PJ Shenoy","year":"2011","unstructured":"Shenoy PJ, Malik N, Sinha R, Nooka A, Nastoupil LJ, Smith M, et al. Racial differences in the presentation and outcomes of chronic lymphocytic leukemia and variants in the United States. Clin Lymphoma Myeloma Leuk. 2011;11:498\u2013506.","journal-title":"Clin Lymphoma Myeloma Leuk"},{"key":"1207_CR18","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1038\/nature14666","volume":"526","author":"XS Puente","year":"2015","unstructured":"Puente XS, Be\u00e0 S, Vald\u00e9s-Mas R, Villamor N, Guti\u00e9rrez-Abril J, Mart\u00edn-Subero JI, et al. Non-coding recurrent mutations in chronic lymphocytic leukaemia. Nature. 2015;526:519\u201324.","journal-title":"Nature"},{"key":"1207_CR19","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1038\/nature15395","volume":"526","author":"DA Landau","year":"2015","unstructured":"Landau DA, Tausch E, Taylor-Weiner AN, Stewart C, Reiter JG, Bahlo J, et al. Mutations driving CLL and their evolution in progression and relapse. Nature. 2015;526:525\u201330.","journal-title":"Nature"},{"key":"1207_CR20","doi-asserted-by":"publisher","first-page":"1507","DOI":"10.1158\/1078-0432.CCR-18-4158","volume":"26","author":"C Brieghel","year":"2020","unstructured":"Brieghel C, da Cunha-Bang C, Yde CW, Schmidt AY, Kinalis S, Nadeu F, et al. The number of signaling pathways altered by driver mutations in chronic lymphocytic leukemia impacts disease outcome. Clin Cancer Res. 2020;26:1507\u201315.","journal-title":"Clin Cancer Res"},{"key":"1207_CR21","doi-asserted-by":"publisher","first-page":"1664","DOI":"10.1038\/s41588-022-01140-w","volume":"54","author":"BA Knisbacher","year":"2022","unstructured":"Knisbacher BA, Lin Z, Hahn CK, Nadeu F, Duran-Ferrer M, Stevenson KE, et al. Molecular map of chronic lymphocytic leukemia and its impact on outcome. Nat Genet. 2022;54:1664\u201374.","journal-title":"Nat Genet"},{"key":"1207_CR22","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1038\/s41588-022-01211-y","volume":"54","author":"P Robbe","year":"2022","unstructured":"Robbe P, Ridout KE, Vavoulis DV, Dr\u00e9au H, Kinnersley B, Denny N, et al. Whole-genome sequencing of chronic lymphocytic leukemia identifies subgroups with distinct biological and clinical features. Nat Genet. 2022;54:1675\u201389.","journal-title":"Nat Genet"},{"key":"1207_CR23","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1002\/ajh.25831","volume":"95","author":"G Kleinstern","year":"2020","unstructured":"Kleinstern G, O\u2019Brien DR, Li X, Tian S, Kabat BF, Rabe KG, et al. Tumor mutational load predicts time to first treatment in chronic lymphocytic leukemia (CLL) and monoclonal B\u2010cell lymphocytosis beyond the CLL international prognostic index. Am J Hematol. 2020;95:906\u201317.","journal-title":"Am J Hematol"},{"key":"1207_CR24","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1158\/1078-0432.CCR-16-0594","volume":"23","author":"L Yu","year":"2017","unstructured":"Yu L, Kim HT, Kasar SN, Benien P, Du W, Hoang K, et al. Survival of Del17p CLL depends on genomic complexity and somatic mutation. Clin Cancer Res. 2017;23:735\u201345.","journal-title":"Clin Cancer Res"},{"key":"1207_CR25","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1038\/s41375-018-0215-9","volume":"33","author":"AC Leeksma","year":"2019","unstructured":"Leeksma AC, Taylor J, Wu B, Gardner JR, He J, Nahas M, et al. Clonal diversity predicts adverse outcome in chronic lymphocytic leukemia. Leukemia. 2019;33:390\u2013402.","journal-title":"Leukemia"},{"key":"1207_CR26","doi-asserted-by":"publisher","first-page":"2118","DOI":"10.1182\/bloodadvances.2023012242","volume":"8","author":"G Kleinstern","year":"2024","unstructured":"Kleinstern G, Boddicker NJ, O\u2019Brien DR, Allmer C, Rabe KG, Norman AD, et al. Tumor mutational load is prognostic for progression to therapy among high-count monoclonal B-cell lymphocytosis. Blood Adv. 2024;8:2118\u201329.","journal-title":"Blood Adv"},{"key":"1207_CR27","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1038\/538161a","volume":"538","author":"AB Popejoy","year":"2016","unstructured":"Popejoy AB, Fullerton SM. Genomics is failing on diversity. Nature. 2016;538:161\u20134.","journal-title":"Nature"},{"key":"1207_CR28","doi-asserted-by":"publisher","first-page":"1963","DOI":"10.1016\/j.ccell.2023.10.003","volume":"41","author":"E Jiagge","year":"2023","unstructured":"Jiagge E, Jin DX, Newberg JY, Perea-Chamblee T, Pekala KR, Fong C, et al. Tumor sequencing of African ancestry reveals differences in clinically relevant alterations across common cancers. Cancer Cell. 2023;41:1963\u201371.","journal-title":"Cancer Cell"},{"key":"1207_CR29","unstructured":"Exome Variant Server, NHLBI Exome Sequencing Project (ESP), Seattle, WA. 2011. http:\/\/evs.gs.washington.edu\/EVS\/."},{"key":"1207_CR30","doi-asserted-by":"publisher","first-page":"D941","DOI":"10.1093\/nar\/gky1015","volume":"47","author":"JG Tate","year":"2019","unstructured":"Tate JG, Bamford S, Jubb HC, Sondka Z, Beare DM, Bindal N, et al. COSMIC: the catalogue of somatic mutations in cancer. Nucleic Acids Res. 2019;47:D941\u2013D947.","journal-title":"Nucleic Acids Res"},{"key":"1207_CR31","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1186\/1471-2105-15-224","volume":"15","author":"KR Kalari","year":"2014","unstructured":"Kalari KR, Nair AA, Bhavsar JD, O\u2019Brien DR, Davila JI, Bockol MA, et al. MAP-RSeq: Mayo analysis pipeline for RNA sequencing. BMC Bioinformatics. 2014;15:224\u201334.","journal-title":"BMC Bioinformatics"},{"key":"1207_CR32","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1093\/bioinformatics\/bts635","volume":"29","author":"A Dobin","year":"2013","unstructured":"Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, et al. STAR: ultrafast universal RNA-seq aligner. Bioinformatics. 2013;29:15\u201321.","journal-title":"Bioinformatics"},{"key":"1207_CR33","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1093\/nar\/gkt214","volume":"4","author":"Y Liao","year":"2013","unstructured":"Liao Y, Smyth G, Shi W. The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote. Nucleic Acids Res. 2013;4:e108.","journal-title":"Nucleic Acids Res"},{"key":"1207_CR34","doi-asserted-by":"publisher","DOI":"10.1093\/nargab\/lqaa078","volume":"2","author":"Y Zhang","year":"2020","unstructured":"Zhang Y, Parmigiani G, Johnson WE. ComBat-seq: batch effect adjustment for RNA-seq count data. NAR Genom Bioinform. 2020;2:lqaa078.","journal-title":"NAR Genom Bioinform"},{"key":"1207_CR35","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1093\/bioinformatics\/btp616","volume":"26","author":"MD Robinson","year":"2010","unstructured":"Robinson MD, McCarthy DJ, Smyth GK. edgeR: a Bioconductor package for differential expression analysis of digital gene expression data. Bioinformatics. 2010;26:139\u201340.","journal-title":"Bioinformatics"},{"key":"1207_CR36","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-09234-6","volume":"10","author":"Y Zhou","year":"2019","unstructured":"Zhou Y, Zhou B, Pache L, Chang M, Khodabakhshi AH, Tanaseichuk O, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10:1523.","journal-title":"Nat Commun"},{"key":"1207_CR37","doi-asserted-by":"publisher","first-page":"W501","DOI":"10.1093\/nar\/gkx372","volume":"45","author":"W Luo","year":"2017","unstructured":"Luo W, Pant G, Bhavnasi YK, Blanchard SG, Brouwer C. Pathview Web: user friendly pathway visualization and data integration. Nucleic Acids Res. 2017;45:W501\u2013W508.","journal-title":"Nucleic Acids Res"},{"key":"1207_CR38","doi-asserted-by":"publisher","DOI":"10.1093\/nar\/30.10.e47","volume":"30","author":"RM Cawthon","year":"2002","unstructured":"Cawthon RM. Telomere measurement by quantitative PCR. Nucleic Acids Res. 2002;30:e47.","journal-title":"Nucleic Acids Res"},{"key":"1207_CR39","doi-asserted-by":"publisher","first-page":"2183","DOI":"10.1038\/s41375-019-0446-4","volume":"33","author":"BMC Jebaraj","year":"2019","unstructured":"Jebaraj BMC, Tausch E, Landau DA, Bahlo J, Robrecht S, Taylor-Weiner AN, et al. Short telomeres are associated with inferior outcome, genomic complexity, and clonal evolution in chronic lymphocytic leukemia. Leukemia. 2019;33:2183\u201394.","journal-title":"Leukemia"},{"key":"1207_CR40","doi-asserted-by":"publisher","first-page":"807","DOI":"10.2144\/000112761","volume":"44","author":"NJ O\u2019Callaghan","year":"2008","unstructured":"O\u2019Callaghan NJ, Dhillon VS, Thomas P, Fenech M. A quantitative real-time PCR method for absolute telomere length. BioTechniques. 2008;44:807\u20139.","journal-title":"BioTechniques"},{"key":"1207_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fonc.2020.612665","volume":"10","author":"BMC Jebaraj","year":"2021","unstructured":"Jebaraj BMC, Stilgenbauer S. Telomere dysfunction in chronic lymphocytic leukemia. Front Oncol. 2021;10:1\u201311.","journal-title":"Front Oncol"},{"key":"1207_CR42","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1016\/j.exphem.2019.02.003","volume":"72","author":"M Hern\u00e1ndez-S\u00e1nchez","year":"2019","unstructured":"Hern\u00e1ndez-S\u00e1nchez M, Rodr\u00edguez-Vicente AE, Gonz\u00e1lez-Gasc\u00f3n y Mar\u00edn I, Quijada-\u00c1lamo M, Hern\u00e1ndez-S\u00e1nchez JM, Mart\u00edn-Izquierdo M, et al. DNA damage response-related alterations define the genetic background of patients with chronic lymphocytic leukemia and chromosomal gains. Exp Hematol. 2019;72:9\u201313.","journal-title":"Exp Hematol"},{"key":"1207_CR43","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","volume":"102","author":"A Subramanian","year":"2005","unstructured":"Subramanian A, Tamayo P, Mootha VK, Mukherjee S, Ebert BL, Gillette MA, et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc Natl Acad Sci USA. 2005;102:15545\u201350.","journal-title":"Proc Natl Acad Sci USA"},{"key":"1207_CR44","doi-asserted-by":"publisher","first-page":"1739","DOI":"10.1093\/bioinformatics\/btr260","volume":"27","author":"A Liberzon","year":"2011","unstructured":"Liberzon A, Subramanian A, Pinchback R, Thorvaldsd\u00f3ttir H, Tamayo P, Mesirov JP. Molecular signatures database (MSigDB) 3.0. Bioinformatics. 2011;27:1739\u201340.","journal-title":"Bioinformatics"},{"key":"1207_CR45","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","volume":"1","author":"A Liberzon","year":"2015","unstructured":"Liberzon A, Birger C, Thorvaldsd\u00f3ttir H, Ghandi M, Mesirov JP, Tamayo P. The molecular signatures database hallmark gene set collection. Cell Syst. 2015;1:417\u201325.","journal-title":"Cell Syst"},{"key":"1207_CR46","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-021-25403-y","volume":"12","author":"J Bloehdorn","year":"2021","unstructured":"Bloehdorn J, Braun A, Taylor-Weiner A, Jebaraj BMC, Robrecht S, Krzykalla J, et al. Multi-platform profiling characterizes molecular subgroups and resistance networks in chronic lymphocytic leukemia. Nat Commun. 2021;12:1\u201318.","journal-title":"Nat Commun"},{"key":"1207_CR47","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00428-005-1264-9","volume":"446","author":"X Dolcet","year":"2005","unstructured":"Dolcet X, Llobet D, Pallares J, Matias-Guiu X. NF-kB in development and progression of human cancer. Virchows Arch. 2005;446:475\u201382.","journal-title":"Virchows Arch"},{"key":"1207_CR48","doi-asserted-by":"publisher","first-page":"303","DOI":"10.1016\/j.clon.2019.02.007","volume":"31","author":"EV Minten","year":"2019","unstructured":"Minten EV, Yu DS. DNA repair: translation to the clinic. Clinical Oncology. 2019;31:303\u201310.","journal-title":"Clinical Oncology"},{"key":"1207_CR49","doi-asserted-by":"publisher","first-page":"549","DOI":"10.1016\/j.ccell.2018.08.019","volume":"34","author":"J Yuan","year":"2018","unstructured":"Yuan J, Hu Z, Mahal BA, Zhao SD, Kensler KH, Pi J, et al. Integrated analysis of genetic ancestry and genomic alterations across cancers. Cancer Cell. 2018;34:549\u201360.","journal-title":"Cancer Cell"},{"key":"1207_CR50","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1038\/s43018-019-0009-7","volume":"1","author":"S Sinha","year":"2020","unstructured":"Sinha S, Mitchell KA, Zingone A, Bowman E, Sinha N, Sch\u00e4ffer AA, et al. Higher prevalence of homologous recombination deficiency in tumors from African Americans versus European Americans. Nat Cancer. 2020;1:112\u201321.","journal-title":"Nat Cancer"},{"key":"1207_CR51","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13824-9","volume":"11","author":"L Sieverling","year":"2020","unstructured":"Sieverling L, Hong C, Koser SD, Ginsbach P, Kleinheinz K, Hutter B, et al. Genomic footprints of activated telomere maintenance mechanisms in cancer. Nat Commun. 2020;11:733.","journal-title":"Nat Commun"},{"key":"1207_CR52","doi-asserted-by":"publisher","first-page":"2246","DOI":"10.1182\/blood-2007-05-092759","volume":"111","author":"G Roos","year":"2008","unstructured":"Roos G, Kr\u00f6ber A, Grabowski P, Kienle D, B\u00fchler A, D\u00f6hner H, et al. Short telomeres are associated with genetic complexity, high-risk genomic aberrations, and short survival in chronic lymphocytic leukemia. Blood. 2008;111:2246\u201352.","journal-title":"Blood"},{"key":"1207_CR53","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1038\/leu.2008.399","volume":"23","author":"D Rossi","year":"2009","unstructured":"Rossi D, Bodoni CL, Genuardi E, Monitillo L, Drandi D, Cerri M, et al. Telomere length is an independent predictor of survival, treatment requirement and Richter\u2019s syndrome transformation in chronic lymphocytic leukemia. Leukemia. 2009;23:1062\u201372.","journal-title":"Leukemia"},{"key":"1207_CR54","doi-asserted-by":"publisher","first-page":"1129","DOI":"10.2217\/pgs-2016-0025","volume":"17","author":"G Hardiman","year":"2016","unstructured":"Hardiman G, Savage JS, Starr Hazard E, Wilson RC, Courtney SM, et al. Systems analysis of the prostate transcriptome in African\u2013American men compared with European\u2013American men. Pharmacogenomics. 2016;17:1129\u201343.","journal-title":"Pharmacogenomics"},{"key":"1207_CR55","doi-asserted-by":"publisher","first-page":"1360","DOI":"10.1016\/j.jid.2021.09.031","volume":"142","author":"A Klopot","year":"2022","unstructured":"Klopot A, Baida G, Kel A, Tsoi LC, Perez White BE, Budunova I. Transcriptome analysis reveals intrinsic pro-inflammatory signaling in healthy African American skin. J Investig Dermatol. 2022;142:1360\u201371.","journal-title":"J Investig Dermatol"},{"key":"1207_CR56","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41598-020-79139-8","volume":"11","author":"U Singh","year":"2021","unstructured":"Singh U, Hernandez KM, Aronow BJ, Wurtele ES. African Americans and European Americans exhibit distinct gene expression patterns across tissues and tumors associated with immunologic functions and environmental exposures. Sci Rep. 2021;11:1\u201314.","journal-title":"Sci Rep"},{"key":"1207_CR57","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1016\/j.psyneuen.2019.04.016","volume":"106","author":"AD Thames","year":"2019","unstructured":"Thames AD, Irwin MR, Breen EC, Cole SW. Experienced discrimination and racial differences in leukocyte gene expression. Psychoneuroendocrinology. 2019;106:277\u201383.","journal-title":"Psychoneuroendocrinology"},{"key":"1207_CR58","doi-asserted-by":"publisher","DOI":"10.1038\/s41523-022-00449-3","volume":"8","author":"M Marczyk","year":"2022","unstructured":"Marczyk M, Qing T, O\u2019Meara T, Yagahoobi V, Pelekanou V, Bai Y, et al. Tumor immune microenvironment of self-identified African American and non-African American triple negative breast cancer. NPJ Breast Cancer. 2022;8:88.","journal-title":"NPJ Breast Cancer"},{"key":"1207_CR59","doi-asserted-by":"publisher","first-page":"891","DOI":"10.1158\/1055-9965.EPI-12-1238","volume":"22","author":"IJ Powell","year":"2013","unstructured":"Powell IJ, Dyson G, Land S, Ruterbusch J, Bock CH, Lenk S, et al. Genes associated with prostate cancer are differentially expressed in African American and European American men. Cancer Epidemiol Biomarkers Prev. 2013;22:891\u20137.","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"1207_CR60","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.urolonc.2020.08.019","volume":"39","author":"IJ Powell","year":"2021","unstructured":"Powell IJ, Chinni SR, Reddy SS, Zaslavsky A, Gavande N. Pro-inflammatory cytokines and chemokines initiate multiple prostate cancer biologic pathways of cellular proliferation, heterogeneity and metastasis in a racially diverse population and underlie the genetic\/biologic mechanism of racial disparity: update. Urol Oncol. 2021;39:34\u201340.","journal-title":"Urol Oncol"}],"container-title":["Blood Cancer Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01207-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01207-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T03:24:23Z","timestamp":1738812263000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41408-024-01207-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,2,6]]},"references-count":60,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["1207"],"URL":"https:\/\/doi.org\/10.1038\/s41408-024-01207-3","relation":{},"ISSN":["2044-5385"],"issn-type":[{"value":"2044-5385","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,2,6]]},"assertion":[{"value":"24 September 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 November 2024","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"16 December 2024","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 February 2025","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"SAP: Research funding has been provided to the institution from Janssen, AstraZeneca, Merck, and Genentech for clinical studies in which SAP is a principal investigator. Honoraria has been provided to the institution from Pharmacyclics, Merck, AstraZeneca, Janssen, Genentech, Amgen, MingSight Pharmaceuticals, TG Therapeutics, Novalgen Limited, Kite Pharma, and AbbVie for SAP\u2019s participation in consulting activities\/advisory board meetings. NEK: Advisory Board for AbbVie, Astra Zeneca, Beigene, Behring, Boehringer Ingelheim Pharmaceuticals, Inc., Dava Oncology, Janssen, Juno Therapeutics, and Pharmacyclics. Data Safety Monitoring Committee for Agios Pharm, AstraZeneca, BMS \u2013 Celgene, and Dren Bio Janssen. Research funding from AbbVie, Acerta Pharma, Bristol Meyer Squib, Celgene, Genentech, Pharmacyclics, Sunesis, and Vincerx. JNA: Consulting: Abbvie, BeiGene, Genentech, Janssen, Pharmacyclics. Research: BeiGene, Genentech, Janssen. Honoraria: Abbvie, AstraZenenca, BeiGene, Genentech, Janssen, Pharmacyclics","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"14"}}